作用类别 | 在研药物数 | 占比(%) | |
抗病毒药(除干扰素外) | 29 | 46.8 | |
干扰素 | 5 | 8.1 | |
免疫调节剂 | 8 | 12.9 | |
肝保护剂 | 1 | 1.6 | |
疫苗 | 治疗用疫苗 | 9 | 14.5 |
预防用疫苗 | 10 | 16.1 |
名称 | 研发公司 | 状态 |
预防性疫苗 | ||
hepatitis-A&B vaccine, Si | Sinovac Biotech | 注册 |
hepatitis-B vaccine-3, GSK | 葛兰素史克 | 注册前 |
hepatitis-B vaccine, Berna-2 | Berna Biotech | Ⅱ期 |
paediatric vaccines, Chiron | Chiron | Ⅱ期 |
DTap-HepB vaccine, LG Life | LG Life Sciences | Ⅰ期 |
DTaP-Hep-B vaccine, SciGen | SciGen | 临床 |
HR-5I | 赛诺菲-安万特 | 临床前 |
hepatitis-B vaccine, Scancell | Scancell | 临床前 |
hepatitis-B vaccine, SciGen | Scancell | 临床前 |
治疗性疫苗 | ||
hepatitis-B vaccine, Berna | Berna Biotech | 注册 |
hepatitis-B vaccine, Oxxon | Oxxon Therapeutics | Ⅱ期 |
hepatitis-B vaccine, Microsci | Microscience | Ⅰ期 |
hepatitis-B vaccine, Innogen-2 | Innogenetics | Ⅰ期 |
hepatitis-B vaccine, Berna-4 | Berna Biotech | 临床前 |
hepatitis-B vaccine, GenPhar | GenPhar | 临床前 |
HBV DNA vaccine, PowderMed | PowderMed | 临床前 |
hepatitis-B vaccine, SciGen | Scancell | 临床前 |
hepatitis-B vaccine, Stressgen | Scancell | 临床前 |
hepatitis-B vaccine, Virexx | ViRexx | 临床前 |
适应症状态 | 名称 | 研发公司 | 产品状态 |
注册 | NOV-205 | Novelos Therapeutics | 注册 |
interferon, Serono (β1a) | Serono | 上市 | |
Ⅲ期临床 | 恩曲他滨(emtricitabine) | Gilead Sciences | 上市 |
替诺福韦酯(tenofovir disoproxil fumarate) | Gilead Sciences | 上市 | |
汰比夫定(telbivudine) | 诺华 | Ⅲ期临床 | |
克拉夫定(clevudine) | Bukwang | Ⅲ期临床 | |
Ⅱ期临床 | remofovir | Metabasis Therapeutics | Ⅱ期临床 |
EHT-899 | Enzo Biochem | Ⅱ期临床 | |
interferon, Biogen (β1a) | Biogen Idec | 上市 | |
Ampligen | Hemispherx Biopharma | Ⅲ期临床 | |
LB-80380 | LG Life Sciences | Ⅱ期临床 | |
valtorcitabine dihydrochloride | 诺华 | Ⅱ期临床 | |
FTC, racemic, Pharmasset | Pharmasset | Ⅱ期临床 | |
elvucitabine | Vion Pharmaceuticals | Ⅱ期临床 | |
HepeX-B | XTL Biopharmaceuticals | Ⅱ期临床 | |
Ⅰ期临床 | Alequel | Enzo Biochem | Ⅱ期临床 |
3DP-3534 | 葛兰素史克 | Ⅰ期临床 | |
MIV-210 | Medivir | Ⅰ期临床 | |
临床前 | robustaflavone | Advanced Life Sciences | 临床前 |
AM-491 | Avexa | 临床前 | |
AVI-4065 | AVI BioPharma | 临床前 | |
anti-hepatitis-B, Axxima | Axxima | 临床前 | |
HBV CTL therapy, Chromos | Chromos Molecular Systems | 临床前 | |
interferon, Hayashibara(alpha) | Hayashibara | Ⅲ期临床 | |
interferon, HGS (alpha) | Human Genome Sciences | Ⅱ期临床 | |
KP-1212/1461 | Koronis | 临床前 | |
MBI-1313 | Migenix | 临床前 | |
VF-233 | Molecules for Health | 临床前 | |
amdoxovir | Non-industrial source | Ⅱ期临床 | |
antivirals, Nucleonics | Nucleonics | 临床前 | |
PA-457 | Panacos | Ⅱ期临床 | |
hepatitis-B therapy, Pharmasse | Pharmasset | 临床前 | |
interferon, SkyePharma (alpha2b) | SkyePharma | 临床前 | |
anti-RA MAb, YuHan | YuHan | 临床前 |
适应症状态 | 名称 | 研发公司 | 产品状态 |
Ⅲ期临床 | PolyA-PolyU | Hemispherx Biopharma | Ⅲ期 |
hepatitis-B prevention,Dynavax | Dynavax Technologies | Ⅲ期 | |
Ⅱ期临床 | CpG-7909 | Coley | Ⅱ期 |
HE-2000 | Hollis-Eden Pharmaceuticals | Ⅱ期 | |
KRN-7000 | Kirin Brewery | Ⅱ期 | |
临床前 | PEG-thymalfasin, SciClone | SciClone Pharmaceuticals | 临床前 |
VIR-401 | Virax | 临床前 | |
Fgl2 MAb | Trillium Therapeutics | 临床前 |
欢迎光临 肝胆相照论坛 (http://hbvhbv.info/forum/) | Powered by Discuz! X1.5 |